Evaluation of the Distortion Correction Data Collection (DCDC) App Software
1 other identifier
interventional
5
1 country
1
Brief Summary
The purpose of the research study is to evaluate how well the Distortion Correction Data Collection (DCDC) App works. The DCDC App is an experimental software application that is being developed at the University of Nebraska Omaha. The DCDC app will map and draw the visual distortions of patients with Age-related Macular degeneration.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 17, 2014
CompletedStudy Start
First participant enrolled
December 29, 2014
CompletedFirst Posted
Study publicly available on registry
January 13, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2016
CompletedSeptember 6, 2023
August 1, 2023
1.2 years
December 17, 2014
August 31, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Functionality of the Distortion Correction Data Collection App (DCDC), as measured by successful usage of the app by subjects.
Subjects will use the app to trace visual distortions. The app will correct these distortions, subjects will give feedback on these corrections. Test will be repeated two times.
3 months
Study Arms (1)
DCDC app
OTHERSubjects will evaluate the DCDC app
Interventions
The DCDC app is an experimental software that allows users to map their visual distortions on a tablet computer.
Eligibility Criteria
You may qualify if:
- years of age or greater
- Diagnosed with age-related macular degeneration (AMD).
- Best corrected visual acuity (BCVA) of (20/40 to 20/200 Snellen equivalent).
- Visual distortion is present in at least one eye, as determined by Amsler grid evaluation.
- Have had the following imaging tests completed within the past three months as part of standard of care: optical coherence tomography (OCT), scanning laser ophthalmoscopy (SLO), and Fluorescein angiography (FA).
- Capable of understanding the requirements of the study, willing to follow study instructions, able to provide written informed consent to participate, and willing to comply with all study requirements.
- Women who are post-menopausal or not otherwise of child-bearing potential -
You may not qualify if:
- Visual field loss from diseases other than AMD.
- Visual distortions from the following conditions other than AMD: epiretinal membrane, diabetic macular edema, central retinal vein occlusion (CRVO) with edema, and cystoid macular edema.
- A medical condition, serious concurrent illness, or extenuating circumstance that would significantly decrease ability to follow study instructions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Nebraska Medical Center, Truhlsen Eye Institute
Omaha, Nebraska, 68198-5540, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vikas Gulati, MD
University of Nebraska
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 17, 2014
First Posted
January 13, 2015
Study Start
December 29, 2014
Primary Completion
March 1, 2016
Study Completion
June 1, 2016
Last Updated
September 6, 2023
Record last verified: 2023-08